Cancellation of state registration. Viramune

November 09, 2017
Active substances:
Trade names:
ICD-10:
I.B20-B24.B24    Disease caused by human immunodeficiency virus [HIV], unspecified
Viramune, nevirapine, HIV, human immunodeficiency, human immunodeficiency virus, HIV treatment

The Ministry of Health of the Russian Federation, in accordance with Article 32 of Federal Law No. 61-FZ of 12.04.2010 "On circulation of medicines", decided to abolish state registration and exclude from the state register of medicinal products for medical use of the medicinal product(registration certificate P N011661 / 02 dated 05.11.2009 issued by Boehringer Ingelheim International GmbH, Germany):

Viramune (trade name of the medicinal product)

Nevirapine (international non-proprietary or grouping or chemical name)

tablets, 200 mg (dosage form, dosage)

Behringer Ingelheim Pharma GmbH & Co. KG, Germany Binger Strasse 173, 55216 Ingelheim am Rhein, Germany Boehringer Ingelheim Ellas A.E., Greece 5 th km Paiania-Markopoulo, 19400 Koropi, Greece ZAO ORTAT, Russia 157092, Kostroma region, Susaninsky district, from. Severnoe, m / r-n Kharitonovo (name and address of the location of the manufacturer of the medicinal product)

on the basis of filing by an authorized legal entity LLC Boehringer Ingelheim a statement on the abolition of state registration of a medicinal product.